Trial Profile
Phase III trial of TD 1211 for opioid-induced constipation planned.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 23 Feb 2013
Price :
$35
*
At a glance
- Drugs Axelopran (Primary)
- Indications Constipation
- Focus Therapeutic Use
- 23 Feb 2013 New trial record